Huihe Healthcare key facts
as of Oct 2026- Manufacturer of intervention medical devices intended for structural heart disease.
- Huihe Healthcare is valued at approximately $1.1B as of Oct 2026 (last reported valuation).
- It has raised $69.7M; the latest was Later Stage VC in Dec 2025.
- Notable investors include Suzhou Oriza Holdings Corporation, IDG Capital, Legend Star, Guotai Junan Innovation Investment, SDIC Unity Capital — 14 tracked in total.
- Status: Privately Held (backing).
Huihe Healthcare's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Huihe Healthcare: the Monday email on marks, rounds and moves
Huihe Healthcare funding rounds
No funding rounds for Huihe Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Huihe Healthcare
14+Membership and data by Private Market View
Huihe Healthcare valuation
Huihe Healthcare's last reported valuation was $1.1 billion in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
Huihe Healthcare investors
14 investors are on record for Huihe Healthcare, including Suzhou Oriza Holdings Corporation, IDG Capital, Legend Star and Guotai Junan Innovation Investment.
About Huihe Healthcare
Manufacturer of intervention medical devices intended for structural heart disease. The company is engaged in the research and development of medical devices specifically for heart diseases, such as the tricuspid valve repair system, providing patients with heart diseases with effective medical solutions.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2019
- Employees
- 16
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.